Cinemark downgraded to Market Perform from Outperform at Barrington

Barrington analyst James Goss downgraded Cinemark to Market Perform from Outperform with no price target. While the third quarter appears set up for a solid close with “Beetlejuice Beetlejuice” and this does suggest the potential for an upward revision to the firm’s estimates, its valuation was based on 2025, which still expects solid growth from 2024 box office levels and the stock reached the firm’s prior price target as a result of the stock doubling year-to-date, the analyst tells investors.